This paper-based (dry) project supports development of safe regenerative medicine methods which impact treatment of unmet clinical needs causing some of societies’ greatest health challenges including type1 diabetes, and end-stage organ failure (kidney/heart/liver).
Genome-wide association studies (GWAS) have identified robust risk loci for Alzheimer’s disease (AD). These findings serve as a starting point for novel biological investigation and treatment strategies.
Prognostic models can be used in health care to predict the probability of an event happening to an individual. For example, knowing that a patient is at high risk of developing type 2 diabetes might change the way they are treated in order to try and prevent or delay this happening.
Stroke is a common complication of atrial fibrillation (AF), which itself is the most widespread cardiac arrhythmia. However, the assessment of stroke risk is not straightforward in a large population of AF patients who are presented in sinus rhythm (SR), including patients after catheter ablation (CA) therapy, i.e.